Ponatinib (for Ph+ ALL)
Treatment used for 1 condition
Total Trials
20
Total Participants
4K
Avg Effectiveness
83%
Avg Safety Score
45%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.